Financial Review: Hims & Hers Health (NYSE:HIMS) vs. Cigna Group (NYSE:CI)

Hims & Hers Health (NYSE:HIMS) and Cigna Group (NYSE:CI) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability and earnings.

Volatility and Risk

Hims & Hers Health has a beta of 2.53, indicating that its stock price is 153% more volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500.

Institutional & Insider Ownership

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 0.6% of Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Hims & Hers Health and Cigna Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35 billion	1.96	$128.37 million	($0.83)	-23.81
Cigna Group	$274.90 billion	0.28	$5.96 billion	$22.66	13.07

Cigna Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Hims & Hers Health and Cigna Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-6.65%	-9.62%	-1.38%
Cigna Group	2.09%	19.57%	5.35%

Analyst Ratings

This is a summary of recent ratings and price targets for Hims & Hers Health and Cigna Group, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1	12	3	0	2.12
Cigna Group	0	8	14	0	2.64

Hims & Hers Health presently has a consensus target price of $31.53, suggesting a potential upside of 59.59%. Cigna Group has a consensus target price of $340.15, suggesting a potential upside of 14.86%. Given Hims & Hers Health’s higher possible upside, research analysts plainly believe Hims & Hers Health is more favorable than Cigna Group.

Summary

Cigna Group beats Hims & Hers Health on 10 of the 14 factors compared between the two stocks.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a consumer-focused telehealth platform that connects patients with licensed healthcare providers and offers access to treatments and wellness products. Its services include online consultations, prescription care and over-the-counter products. The company serves a range of health needs, including hair loss, sexual health, skin care, mental health and weight management. Its platform also offers primary care and other services, with offerings varying by location and individual eligibility.

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.